Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Netherlands Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20062
20072
20082
20092
20113
20122
20131
20142
20154
20163
20174
20187
20198
20204
20213
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
The Netherlands Cancer Institute5
European Organisation for Research and Treatment of Cancer - EORTC4
Amgen2
Bayer2
Bristol-Myers Squibb2
Clovis Oncology, Inc.2
Daiichi Sankyo2
ETOP IBCSG Partners Foundation2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung62
Neoplasm Metastasis10
Lung Neoplasms8
Neoplasms8
Head and Neck Neoplasms4
Carcinoma3
Pancreatic Neoplasms3
Adenocarcinoma2
Adenocarcinoma of Lung2
Carcinoma, Bronchogenic2

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.